Clinical Trial Update: Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Immuncell-LC versus non-treatment in hepatocellular carcinoma completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immuncell-LC

Snippet

Sponsor: GC Cell Corporation | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2015-09-24